Skip to main content

Table 1 Demographic and clinical characteristics, by partner type

From: Mortality in members of HIV-1 serodiscordant couples in Africa and implications for antiretroviral therapy initiation: Results of analyses from a multicenter randomized trial

Characteristic HIV-1 infected partner HIV-1-uninfected partner
  (N = 3295) (N = 3295)
  Men Women Men Women
  (n = 1073) (n = 2222) (n = 2222) (n = 1073)
Age, median (IQR) 37 (32,45) 30 (25, 35) 35 (30, 42) 31 (25, 38)
Informal settlement 404 (38%) 859 (39%) 869 (39%) 390 (39%)
Married to study partner 866 (81%) 1627 (73%) 1636 (74%) 864 (81%)
Cohabiting with study partner 1002 (93%) 1970 (89%) 1983 (89%) 1000 (93%)
>8 years of education completed 512 (48%) 901 (41%) 1157 (52%) 401 (37%)
Any income 638 (59%) 546 (25%) 1331 (60%) 280 (26%)
CD4, median, cells/mm3 (IQR)    - -
Enrollment 426 (334, 571) 481 (354, 664)   
Final visit 394 (276, 544) 437 (312, 617)   
HIV-1 plasma RNA, median, log10 copies/mL (IQR)    - -
Enrollment 4.2 (3.5, 4.8) 3.8 (3.0, 4.4)   
Final visit 4.4 (3.6, 5.0) 4.0 (3.2, 4.7)   
Ever on ART over follow up 112 (10%) 178 (8%) - -
Highest WHO stage of HIV-1    - -
< 3 806 (75%) 1720 (77%)   
3 243 (23%) 436 (20%)   
4 24 (2%) 66 (3%)   
  1. ¶Informal Settlement, as defined by study participants.
\